- Di sistema
- The conference brings together expert oncologists, researchers, molecular biologists, radiologists, and surgeons to discuss the latest advancements in the diagnosis, management, and treatment of this complex disease. The event focuses on understanding the molecular signatures of breast cancer, analyzing the genetic and biomolecular profiles that differentiate the various subtypes of the disease. This knowledge is crucial for developing personalized therapies, enhancing their effectiveness, and reducing side effects. Key topics include the role of hormone receptors (er and pr) and her2 biomarkers, along with the discovery of new therapeutic targets.